<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from url=(0078)file://W:\ATHENADSS\doc\ATHENA\drug_evidence\Hypertension_and_DiureticsSS.html -->
<HTML><HEAD><TITLE>Hypertension and Thiazides</TITLE>
<META content="text/html; charset=iso-8859-1" http-equiv=Content-Type>
<META content="MSHTML 5.00.3103.1000" name=GENERATOR>
<script language="JavaScript">
<!--
function MM_goToURL() { //v3.0
  var i, args=MM_goToURL.arguments; document.MM_returnValue = false;
  for (i=0; i<(args.length-1); i+=2) eval(args[i]+".location='"+args[i+1]+"'");
}
//-->
</script>
</HEAD>
<BODY bgColor=#ebfbfe text=#000000>
<ul>
  <li><font color="#660066" face="MS Sans Serif" size="2">Low dose thiazides ( 
    <img src="../lessthansign.gif" width="7" height="10"> 25mg/day) reduces risk 
    of death, stroke and coronary heart disease of patients with primary hypertension 
    (Table 1). <A 
  href="file:///E|/VA/Tabs/Original%20papers/Hypertension%20and%20Thiazides_content.html#Wright" onClick="MM_goToURL('parent.frames[\'main_banner\']','file:///E|/VA/Tabs/Banners/PubMed.htm','parent.frames[\'main_content\']','file:///E|/VA/Tabs/Original%20papers/Hypertension%20and%20Thiazides_content.html#Wright');return document.MM_returnValue">Wright 
    1999</A>, <A 
  href="file:///E|/VA/Tabs/Original%20papers/Hypertension%20and%20Thiazides_content.html" onClick="MM_goToURL('parent.frames[\'main_banner\']','file:///E|/VA/Tabs/Banners/PubMed.htm','parent.frames[\'main_content\']','file:///E|/VA/Tabs/Original%20papers/Hypertension%20and%20Thiazides_content.html#Psaty');return document.MM_returnValue">Psaty 
    1997</A></font></li>
  <li><font color="#660066" face="MS Sans Serif" size="2">Reduction in systolic 
    blood pressure was significantly greater (by ~2mmHg) with thiazides than with 
    beta adrenergic receptor antagonists or calcium channel blockers. <a 
  href="file:///E|/VA/Tabs/Original%20papers/Hypertension%20and%20Thiazides_content.html#Wright" onClick="MM_goToURL('parent.frames[\'main_banner\']','file:///E|/VA/Tabs/Banners/PubMed.htm','parent.frames[\'main_content\']','file:///E|/VA/Tabs/Original%20papers/Hypertension%20and%20Thiazides_content.html#Wright');return document.MM_returnValue">Wright 
    1999</a></font> </li>
  <li><font color="#660066" face="MS Sans Serif" size="2">Patients reported a 
    31% (95% CI 24-37) lower rate of withdrawal due to adverse effects with thiazides 
    as compared with beta adrenergic receptor antagonists. <a 
  href="file:///E|/VA/Tabs/Original%20papers/Hypertension%20and%20Thiazides_content.html#Wright" onClick="MM_goToURL('parent.frames[\'main_banner\']','file:///E|/VA/Tabs/Banners/PubMed.htm','parent.frames[\'main_content\']','file:///E|/VA/Tabs/Original%20papers/Hypertension%20and%20Thiazides_content.html#Wright');return document.MM_returnValue">Wright 
    1999</a></font></li>
</ul>
<div align="center"><font color="#660066" face="Times New Roman, Times, serif" size="2"><b><font face="Geneva, Arial, Helvetica, san-serif">Table 
  1: Systematic Review of First Line Therapy for Hypertension: Effectiveness of 
  Low Dose Thiazides</font></b></font><font color="#660066" face="Geneva, Arial, Helvetica, san-serif" size="-1"> 
  <b><br>
  </b></font><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="-1"></font> 
</div>
<TABLE border=1 cellSpacing=0 width="96%" align="center">
  <TBODY> 
  <TR> 
    <TD bgColor=#ffffe1 rowSpan=2 width="10%" valign="middle" align="center"> 
      <DIV align=center> 
        <P><font face="Verdana, Arial, Helvetica, sans-serif" size="1"><B><font color="#660033">Systematic 
          Review</font></B></font></P>
      </DIV>
    </TD>
    <TD bgColor=#ffffe1 rowSpan=2 width="9%" align="center" valign="middle"> 
      <DIV align=center><font color="#660033" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Population</B></font></DIV>
    </TD>
    <TD bgColor=#ffffe1 rowSpan=2 width="10%" align="center" valign="middle"> 
      <DIV align=center><font color="#660033" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Intervention</B></font></DIV>
    </TD>
    <TD bgColor=#ffffe1 rowSpan=2 width="9%" align="center" valign="middle"> 
      <DIV align=center><font color="#660033" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Duration 
        (minimum)</B></font></DIV>
    </TD>
    <TD bgColor=#ffffe1 rowSpan=2 width="17%" align="center" valign="middle"> 
      <DIV align=center><font color="#660033" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Outcome</B></font></DIV>
    </TD>
    <TD bgColor=#ffffe1 colSpan=2> 
      <DIV align=center><font color="#660033" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Events/Sample 
        size (%)</B></font></DIV>
    </TD>
    <TD bgColor=#ffffe1 rowSpan=2 width="12%"> 
      <DIV align=center><font color="#660033" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Relative 
        Risk (95%CI)</B></font></DIV>
    </TD>
    <TD bgColor=#ffffe1 rowSpan=2 width="13%"> 
      <DIV align=center><font color="#660033" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Relative 
        Risk Reduction (95% CI) </B></font></DIV>
    </TD>
  </TR>
  <TR> 
    <TD bgColor=#ffffe1 width="9%"> 
      <DIV align=center><font face="Verdana, Arial, Helvetica, sans-serif"><b><font color="#660033" size="1"><I>Thiazide 
        diuretics</I></font></b></font></DIV>
    </TD>
    <TD bgColor=#ffffe1 width="11%"> 
      <DIV align=center><font face="Verdana, Arial, Helvetica, sans-serif"><b><font color="#660033" size="1"><I>Placebo</I></font></b></font></DIV>
    </TD>
  </TR>
  <TR bgColor=#fee0e9> 
    <TD rowSpan=4 width="10%" align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Wright, 
      1999</B></font></TD>
    <TD bgColor=#fee0e9 rowSpan=4 width="9%" align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1">5 
      trials (9162 patients)</font></TD>
    <TD rowSpan=4 width="10%" align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Low 
      dose thiazide diuretics vs. placebo</B></font></TD>
    <TD rowSpan=4 width="9%" align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1">1 
      year</font></TD>
    <TD height=38 width="17%" align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Death 
      (all causes)</B></font></TD>
    <TD height=38 width="9%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1">521/4349 
        (12%)</font></div>
    </TD>
    <TD height=38 width="11%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1">720/5163 
        (14%)</font></div>
    </TD>
    <TD height=38 width="12%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>0.89<br>
        (0.81-0.99)</B></font></div>
    </TD>
    <TD height=38 width="13%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>11% 
        (1-19)</B></font></div>
    </TD>
  </TR>
  <TR> 
    <TD bgColor=#fee0e9 width="17%" align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Coronary 
      artery disease</B></font></TD>
    <TD bgColor=#fee0e9 width="9%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1">221/4349 
        (5.1%)</font></div>
    </TD>
    <TD bgColor=#fee0e9 width="11%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1">374/5163 
        (7.2%)</font></div>
    </TD>
    <TD bgColor=#fee0e9 width="12%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>0.71<br>
        (0.60-0.84)</B></font></div>
    </TD>
    <TD bgColor=#fee0e9 width="13%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>29% 
        (16-40)</B></font></div>
    </TD>
  </TR>
  <TR> 
    <TD bgColor=#fee0e9 width="17%" align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Stroke 
      (fatal and non fatal)</B></font></TD>
    <TD bgColor=#fee0e9 width="9%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1">197/4349 
        (4.5%)</font></div>
    </TD>
    <TD bgColor=#fee0e9 width="11%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1">355/5163 
        (6.9%)</font></div>
    </TD>
    <TD bgColor=#fee0e9 width="12%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>0.66<br>
        (0.56-0.79)</B></font></div>
    </TD>
    <TD bgColor=#fee0e9 width="13%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>34% 
        (21-44)</B></font></div>
    </TD>
  </TR>
  <TR> 
    <TD bgColor=#fee0e9 width="17%" align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>Total 
      cardiovascular events*</B></font></TD>
    <TD bgColor=#fee0e9 width="9%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1">527/4349 
        (12.1%)</font></div>
    </TD>
    <TD bgColor=#fee0e9 width="11%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1">899/5163 
        (17.4%)</font></div>
    </TD>
    <TD bgColor=#fee0e9 width="12%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>0.68<br>
        (0.62-0.75)</B></font></div>
    </TD>
    <TD bgColor=#fee0e9 width="13%"> 
      <div align="center"><font color="#660066" face="Verdana, Arial, Helvetica, sans-serif" size="1"><B>32% 
        (25-38)</B></font></div>
    </TD>
  </TR>
  <TR bgColor=#fee0e9> 
    <TD colSpan=9 height=28><font color="#660033" face="Verdana, Arial, Helvetica, sans-serif" size="1">* 
      includes stroke, coronary artery disease, congestive heart failure and other 
      significant events such as ruptured aneurysm.</font></TD>
  </TR>
  </TBODY> 
</TABLE>
</BODY></HTML>
